Skip to main content
Erschienen in: Herz 2/2014

01.03.2014 | e-Herz: Original article

Left atrial deformation and nonischemic dilated cardiomyopathy

A 2D speckle-tracking imaging study

verfasst von: A. Guler, K.M. Tigen, C. Dundar, T. Karaahmet, C.Y. Karabay, S.M. Aung, T. Akgun, M. Bulut, C. Kirma

Erschienen in: Herz | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Left ventricular filling pressure (LVFP) is raised by the compromised contraction and impaired ventricular compliance in dilated hearts with systolic dysfunction. Timely recognition and staging of this condition are important for planning of the treatment strategy and making the prognosis. Two-dimensional speckle- tracking echocardiography (2D-STE) has recently enabled the quantification of left atrial (LA) myocardial deformation dynamics. In this study, echocardiographic indicators of increased LVFP and NT-pro-BNP were compared with LA strain measured by 2D-STE.

Methods

A total of 49 nonischemic dilated cardiomyopathy (DCMP) patients were included in the study. All patients underwent standard 2D echocardiography. In the 2D-STE analysis of the LA, global longitudinal LA strain during ventricular systole (GLAs-res) and strain during late diastole (GLAs-pump) were obtained. NT-pro-BNP levels were measured. The patients were divided into two groups—normal (group 1) and increased (group 2) LVFP—according to E/A ratio, E velocity, and E/E’ ratio.

Results

LAVi-max, LAVi-min, and NT-pro-BNP were higher in group 2, whereas LAtotalEF, LAactiveEF, GLAs-res, and GLAs-pump were lower. In univariate analysis, a good negative correlation was seen between GLAs-res vs. NT-pro-BNP, GLAs-res vs. LAVi-max, and GLAs-res vs. E/E’ ratio; a good negative correlation was present between GLAs-pump vs. NT-pro-BNP, GLAs-pump vs. LAVi-max, and GLAs-pump vs. E/E’ ratio. LAVi-max, LAactiveEF, NT-pro-BNP, GLas-res, and GLAs-pump were studied by logistic regression analysis. GLAs-res (p = 0.009, OR = 0.593, 95 % CI 0.4–0.877), NT-pro-BNP (p = 0.028, OR = 1.027, 95 % CI 1.003–1.052), and LAactiveEF (p = 0.022, OR = 0.001, 95 % CI 0.001–0.024) were found to be independent predictors of increased LVFP.

Conclusion

2D-STE-based LA function is impaired in patients with nonischemic DCMP. LA reservoir and pump function parameters together with NT-pro-BNP levels might be useful in estimating LVFP in this patient group.
Literatur
1.
Zurück zum Zitat Stevenson WG, Stevenson LW, Middlekauff HR et al (1995) Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 26:1417–1423PubMedCrossRef Stevenson WG, Stevenson LW, Middlekauff HR et al (1995) Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 26:1417–1423PubMedCrossRef
2.
Zurück zum Zitat Rihal CS, Nishimura RA, Hatle LK et al (1994) Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation 90:2772–2779PubMedCrossRef Rihal CS, Nishimura RA, Hatle LK et al (1994) Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation 90:2772–2779PubMedCrossRef
3.
Zurück zum Zitat Skaluba SJ, Litwin SE (2004) Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation 109:972–977PubMedCrossRef Skaluba SJ, Litwin SE (2004) Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation 109:972–977PubMedCrossRef
4.
Zurück zum Zitat Haskell RJ, French WI (1988) Accuracy of left atrial and pulmonary artery wedge pressure in pure mitral regurgitation in predicting ventricular end-diastolic pressure. Am J Cardiol 61:136–141PubMedCrossRef Haskell RJ, French WI (1988) Accuracy of left atrial and pulmonary artery wedge pressure in pure mitral regurgitation in predicting ventricular end-diastolic pressure. Am J Cardiol 61:136–141PubMedCrossRef
5.
Zurück zum Zitat Keogh AM, Baron DW, Hikie JB (1990) Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy for cardiac transplantation. Am J Cardiol 65:903–908PubMedCrossRef Keogh AM, Baron DW, Hikie JB (1990) Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy for cardiac transplantation. Am J Cardiol 65:903–908PubMedCrossRef
6.
Zurück zum Zitat Stevenson WG, Stevenson LW, Middlekauff HR et al (1995) Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 26:1417–1423PubMedCrossRef Stevenson WG, Stevenson LW, Middlekauff HR et al (1995) Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 26:1417–1423PubMedCrossRef
7.
Zurück zum Zitat Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22(2):107–133PubMedCrossRef Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22(2):107–133PubMedCrossRef
8.
Zurück zum Zitat Paulus WJ, Tsche C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550PubMedCrossRef Paulus WJ, Tsche C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550PubMedCrossRef
9.
Zurück zum Zitat Hillis GS, Moller JE, Pellikka PA et al (2004) Noninvasive estimation of left ventricular filling pressure by E/e’ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 43:360–367PubMedCrossRef Hillis GS, Moller JE, Pellikka PA et al (2004) Noninvasive estimation of left ventricular filling pressure by E/e’ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 43:360–367PubMedCrossRef
10.
Zurück zum Zitat Mullens W, Borowski AG, Curtin RJ et al (2009) Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure. Circulation 119:62–70PubMedCentralPubMedCrossRef Mullens W, Borowski AG, Curtin RJ et al (2009) Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure. Circulation 119:62–70PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Bruch C, Grude M, Müller J et al (2005) Usefulness of tissue Doppler imaging for estimation of left ventricular filling pressures in patients with systolic and diastolic heart failure. Am J Cardiol 95:892–895PubMedCrossRef Bruch C, Grude M, Müller J et al (2005) Usefulness of tissue Doppler imaging for estimation of left ventricular filling pressures in patients with systolic and diastolic heart failure. Am J Cardiol 95:892–895PubMedCrossRef
12.
Zurück zum Zitat Lee CY, Burnett JC Jr (2007) Natriuretic peptides and therapeutic applications. Heart Fail Rev 12(2):131–142PubMedCrossRef Lee CY, Burnett JC Jr (2007) Natriuretic peptides and therapeutic applications. Heart Fail Rev 12(2):131–142PubMedCrossRef
13.
Zurück zum Zitat McCullough PA, Nowak RM, McCord J et al (2002) B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106(4):416–422PubMedCrossRef McCullough PA, Nowak RM, McCord J et al (2002) B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106(4):416–422PubMedCrossRef
14.
Zurück zum Zitat Januzzi JL Jr (2006) Natriuretic peptide testing: a window into the diagnosis and prognosis of heart failure. Cleve Clin J Med 73(2):149–152, 155–157PubMedCrossRef Januzzi JL Jr (2006) Natriuretic peptide testing: a window into the diagnosis and prognosis of heart failure. Cleve Clin J Med 73(2):149–152, 155–157PubMedCrossRef
15.
Zurück zum Zitat Lang RM, Bierig M, Devereux RB et al (2006) American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 7(2):79–108PubMedCrossRef Lang RM, Bierig M, Devereux RB et al (2006) American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 7(2):79–108PubMedCrossRef
16.
Zurück zum Zitat Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23(7):685–713PubMedCrossRef Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23(7):685–713PubMedCrossRef
17.
Zurück zum Zitat Kircher B, Abbott JA, Pau S et al (1991) Left atrial volume determination by biplane two-dimensional echocardiography: validation by cine computed tomography. Am Heart J 121(3 Pt 1):864–871PubMedCrossRef Kircher B, Abbott JA, Pau S et al (1991) Left atrial volume determination by biplane two-dimensional echocardiography: validation by cine computed tomography. Am Heart J 121(3 Pt 1):864–871PubMedCrossRef
18.
Zurück zum Zitat Kurt M, Tanboga IH, Aksakal E et al (2012) Relation of left ventricular end-diastolic pressure and N-terminal pro-brain natriuretic peptide level with left atrial deformation parameters. Eur Heart J Cardiovasc Imaging 13(6):524–530PubMedCrossRef Kurt M, Tanboga IH, Aksakal E et al (2012) Relation of left ventricular end-diastolic pressure and N-terminal pro-brain natriuretic peptide level with left atrial deformation parameters. Eur Heart J Cardiovasc Imaging 13(6):524–530PubMedCrossRef
19.
Zurück zum Zitat Ohtani K, Yutani C, Nagata S et al (1995) High prevalence of atrial fibrosis in patients with dilated cardiomyopathy. J Am Coll Cardiol 25:1162–1169PubMedCrossRef Ohtani K, Yutani C, Nagata S et al (1995) High prevalence of atrial fibrosis in patients with dilated cardiomyopathy. J Am Coll Cardiol 25:1162–1169PubMedCrossRef
20.
Zurück zum Zitat Triposkiadis F, Pitsavos C, Boudoulas H et al (1994) Left atrial myopathy in idiopathic dilated cardiomyopathy. Am Heart J 128(2):308–315PubMedCrossRef Triposkiadis F, Pitsavos C, Boudoulas H et al (1994) Left atrial myopathy in idiopathic dilated cardiomyopathy. Am Heart J 128(2):308–315PubMedCrossRef
21.
Zurück zum Zitat Tigen K, Karaahmet T, Kirma C et al (2010) The association of functional mitral regurgitation and anemia in patients with non-ischemic dilated cardiomyopathy. Cardiol J 17(3):274–280PubMed Tigen K, Karaahmet T, Kirma C et al (2010) The association of functional mitral regurgitation and anemia in patients with non-ischemic dilated cardiomyopathy. Cardiol J 17(3):274–280PubMed
22.
Zurück zum Zitat D’Andrea A, Caso P, Romano S et al (2009) Association between left atrial myocardial function and exercise capacity in patients with either idiopathic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study. Int J Cardiol 132(3):354–363CrossRef D’Andrea A, Caso P, Romano S et al (2009) Association between left atrial myocardial function and exercise capacity in patients with either idiopathic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study. Int J Cardiol 132(3):354–363CrossRef
Metadaten
Titel
Left atrial deformation and nonischemic dilated cardiomyopathy
A 2D speckle-tracking imaging study
verfasst von
A. Guler
K.M. Tigen
C. Dundar
T. Karaahmet
C.Y. Karabay
S.M. Aung
T. Akgun
M. Bulut
C. Kirma
Publikationsdatum
01.03.2014
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe 2/2014
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-013-3817-z

Weitere Artikel der Ausgabe 2/2014

Herz 2/2014 Zur Ausgabe

Aktuelle Kardiologie

Aktuelle Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.